2026-05-07 19:06 UTC
#Evidence that #mRNA #influenza #vaccines provide higher levels of protection than the standard one. #vaccination #vaccine
https://www.nejm.org/doi/full/10.1056/NEJMoa2516491
Replies (1)
-
@michaelmeckler@mastodonapp.uk 2026-05-08 10:58
@MartMichaelis@mastodonapp.uk An interesting study. I was able to read only the summary, so I do not know whether this was discussed in the full article, but I was curious as to why subjects reported greater adverse reactions that were mild/minor (injection-site pain, fatigue, headache, myalgia). I might want to know more about the demographic distribution within the two groups, which are quite large (>20K) and so, presumably, would be fairly similar. This detail in the summary struck me as curious, and perhaps worthy of further study, in order to find ways to reduce these minor adverse reactions to prevent reluctance of uptake for these mRNA vaccines. Any thoughts?